Related Experiment Video
Updated: Jun 15, 2025
Alginate Hydrogels for Three-Dimensional Organ Culture of Ovaries and Oviducts
Published on: June 20, 2011
Advancements in Hydrogel-Based Therapies for Ovarian Cancer: A Review
1Harbin Medical University, Harbin, Heilongjiang, China. 1372551244@qq.com.
Abstract:
Ovarian cancer, the most deadly gynecologic malignancy, is often resistant to conventional antitumor therapy due to various factors such as severe side effects, unexpected recurrence, and significant tissue damage. The limitations of current treatments and the resistance of invasive tumor cells contribute to these challenges. Hydrogel therapy has recently emerged as a potential treatment option for ovarian cancer, offering advantages such as controllability, biocompatibility, high drug loading capacity, prolonged drug release, and responsiveness to specific stimuli. Hence, the utilization of biodegradable hydrogels as carriers for chemotherapeutic agents has emerged as a significant concern in the field. Injectable hydrogel-based drug delivery systems, in particular, have demonstrated superior efficacy compared to traditional systemic chemotherapy for cancer treatment. The pliability of hydrogel therapy allows for access to anatomical regions that may be challenging for surgical intervention. This review article examines recent advancements in the application of hydrogels for diagnosing and treating ovarian cancer, while also proposing a novel direction for the use of hydrogel technology in this context. The objective of this article is to offer a novel point of reference and serve as a source of inspiration for the advancement of more precise and individualized cancer therapies.
Insights
Hydrogel therapy offers a promising new approach for treating ovarian cancer, overcoming limitations of conventional treatments by providing controlled drug delivery and improved efficacy. This innovative method enhances therapeutic outcomes for this deadly gynecologic malignancy.
Area of Science:
- Biomaterials Science
- Oncology
- Drug Delivery Systems
Background:
- Ovarian cancer is the deadliest gynecologic malignancy, often exhibiting resistance to conventional therapies.
- Current treatments face challenges including severe side effects, recurrence, and tissue damage.
- Limitations stem from treatment inefficacy and invasive tumor cell resistance.
Purpose of the Study:
- To review recent advancements in hydrogel applications for ovarian cancer diagnosis and treatment.
- To explore novel directions for hydrogel technology in ovarian cancer care.
- To provide a reference for developing precise and individualized cancer therapies.
Main Methods:
- Review of current literature on hydrogel therapy for ovarian cancer.
- Analysis of hydrogel properties: controllability, biocompatibility, drug loading, release kinetics, and stimuli-responsiveness.
- Comparison of injectable hydrogel systems with traditional systemic chemotherapy.
Main Results:
- Hydrogel therapy demonstrates advantages over conventional treatments for ovarian cancer.
- Injectable hydrogel-based systems show superior efficacy compared to systemic chemotherapy.
- Hydrogels offer controlled, prolonged drug release and access to difficult anatomical regions.
Conclusions:
- Biodegradable hydrogels are effective carriers for chemotherapeutic agents in ovarian cancer.
- Hydrogel therapy presents a viable, advanced treatment strategy for ovarian cancer.
- This technology holds potential for more precise and personalized ovarian cancer therapies.
